ArticleCancers2020

Effect of Baseline Characteristics on Cabazitaxel Treatment Duration in Patients with Metastatic Castration-Resistant Prostate Cancer: A Post Hoc Analysis of the Compassionate Use/Expanded Access Programs and CAPRISTANA Registry.

Zafar Malik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.